0 likes | 2 Views
U.S. Veterinary Diagnostics Market
E N D
The U.S. veterinary diagnostics market reached $3.39 billion in 2023 and is projected to grow 8.6% annually through 2032. The market is driven by rising pet ownership - with 78% of U.S. pet owners acquiring pets during the pandemic - and increased spending on pet healthcare. Key market segments include: Products: Reagents & consumables lead the market, supported by growing R&D in diagnostic kits Techniques: Immunodiagnostics dominates, particularly for detecting chronic diseases like cancer Animal Type: Companion animals represent the largest segment, with 70% of U.S. households owning pets End Users: Veterinary reference laboratories hold the largest share Market growth faces some constraints from high testing costs, with basic blood work for dogs ranging from $100-200 per test. Leading companies include: IDEXX Laboratories (market leader) Zoetis Services LLC Heska Corporation Virbac Zomedica Corp. VCA Animal Hospitals Recent developments focus on point-of-care diagnostics and AI integration, with companies like Heska expanding through acquisitions to enter the rapid assay diagnostics market. Report- Fortune Business Insights - U.S. Veterinary Diagnostics Market Size | Industry Trends [2032] https://www.fortunebusinessinsights.com/u-s-veterinary-diagnostics-market-107887